What medications are recommended for managing an acute cough, including options for dry and productive coughs?

Medication for Acute Cough Management

For acute cough due to bronchitis or upper respiratory infection, avoid routine prescription of antitussives, antihistamines, or other cough medications, as they lack proven efficacy and may cause harm—the exception being ipratropium bromide inhaler, which has strong evidence for both bronchitis and URI-related cough. 1, 2

Evidence-Based Treatment Algorithm

Step 1: Identify the Cough Type and Underlying Cause

For Chronic or Acute Bronchitis:

• Dextromethorphan 60 mg is the first-line central cough suppressant with Grade B evidence 2
• The 60 mg dose is critical—lower over-the-counter doses are subtherapeutic and ineffective 2
• Ipratropium bromide inhaler carries Grade A evidence as the only inhaled anticholinergic proven effective for bronchitis-related cough 2
• Codeine 30 mg reduces cough intensity by 40-60% but has greater adverse effects (Grade B recommendation) 2

For Upper Respiratory Infection (URI)/Common Cold:

• Do NOT use dextromethorphan or codeine—they have Grade D evidence (no benefit) for URI-related cough 2
• Ipratropium bromide inhaler retains Grade A evidence and is the preferred pharmacologic option 2
• Older antihistamine-decongestant combinations may provide modest benefit, but most over-the-counter formulations lack validation 2
• Non-pharmacologic measures like honey with lemon or menthol inhalation offer short-term relief 2

Step 2: Apply the Treatment Decision Tree

If bronchitis is suspected:

1. Prescribe dextromethorphan 60 mg OR ipratropium inhaler 2
2. Avoid antibiotics, NSAIDs, beta-agonists, and corticosteroids unless bacterial superinfection develops 1
3. Reassess if cough persists beyond expected duration 1

If URI/common cold is diagnosed:

1. Prescribe ipratropium inhaler as first-line 2
2. Consider antihistamine-decongestant combinations as second-line only 2
3. Recommend supportive care and hydration 3

If etiology is uncertain:

• Default to ipratropium inhaler, which has Grade A evidence for both conditions 2

Step 3: Avoid Common Prescribing Pitfalls

Do NOT prescribe the following (all have Grade D evidence or lack of efficacy):

• Albuterol for cough not attributable to asthma 2
• Mucolytics (guaifenesin) for cough suppression in chronic bronchitis 2
• Routine antibiotics for uncomplicated acute bronchitis—no difference in cough duration compared to placebo 1
• Oral NSAIDs like ibuprofen—showed no benefit over placebo in reducing cough days (median 9 vs 11 days) 1
• Inhaled corticosteroids or oral corticosteroids for simple acute bronchitis 1

Critical Evidence Considerations

The Chest Expert Panel (2020) found insufficient evidence to support routine use of antibiotics, antivirals, antitussives, beta-agonists, anticholinergics, corticosteroids, or NSAIDs for acute bronchitis 1. A randomized trial of 416 patients showed ibuprofen, amoxicillin-clavulanic acid, and placebo all resulted in similar cough duration (9-11 days) 1.

The Cochrane review (2014) concluded there is no good evidence for or against OTC cough medicines in acute cough, with variable results across antitussives, expectorants, and antihistamines 4. This systematic review emphasized the potential for serious harm, particularly with antihistamines and dextromethorphan in children 4.

Real-world Indian data (2025) revealed problematic patterns: antibiotics were prescribed in 60% of productive cough and 53% of nonproductive cough cases, despite lack of evidence 5. This represents significant antibiotic overuse that should be avoided 5.

Special Populations and Situations

For nocturnal cough disrupting sleep:

• First-generation sedating antihistamines may improve sleep disruption 2
• Limit to short-term symptomatic relief only 2

For productive cough:

• Maintain good hydration 3
• Avoid antitussives that suppress the productive cough reflex 2

When to consider antibiotics:

• Only if acute bronchitis worsens and bacterial superinfection is clinically suspected 1
• Rule out alternative diagnoses: COPD exacerbation, asthma, bronchiectasis, bacterial sinusitis 1

Codeine-based preparations:

• Reserve as last resort for unexplained chronic cough when all other treatments have failed 3
• Not recommended for routine acute cough management 2

Duration of Therapy

Limit all cough medication therapy to 3-5 days for symptomatic relief 5. Reassess if symptoms persist or worsen beyond this timeframe 1.